Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dennis Shaw

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 24, 2019
Phase II Trial of Response-Based Radiation Therapy for Patients With Localized CNS Nongerminomatous Germ Cell Tumors: A Children's Oncology Group StudyJason Fangusaro, Shengjie Wu, Shannon MacDonald, et al.
Human Molecular Genetics|February 22, 2020
Longitudinal measures of RNA expression and disease activity in FSHD muscle biopsiesChao-Jen Wong, Leo H Wang, Seth D Friedman, et al.
Scientific Reports|July 4, 2024
AI driven analysis of MRI to measure health and disease progression in FSHDLara Riem, Olivia DuCharme, Matthew Cousins, et al.
Neuro-Oncology|December 1, 2021
Phase II trial of response-based radiation therapy for patients with localized germinoma: a Children's Oncology Group studyUte Bartels, Arzu Onar-Thomas, Sunita K Patel, et al.
International Journal of Radiation Oncology, Biology, Physics|January 6, 2022
A Phase 2 Trial of Response-Based Radiation Therapy for Localized Central Nervous System Germ Cell Tumors: Patterns of Failure and Radiation Dosimetry for Nongerminomatous Germ Cell TumorsErin S Murphy, Girish Dhall, Jason Fangusaro, et al.
Human Molecular Genetics|October 13, 2018
MRI-informed muscle biopsies correlate MRI with pathology and DUX4 target gene expression in FSHDLeo H Wang, Seth D Friedman, Dennis Shaw, et al.
Neuro-Oncology|June 9, 2025
Phase 3 randomized trial of high-dose methotrexate for young children with high-risk embryonal brain tumors: A report from the Children's Oncology GroupClaire Mazewski, Sarah E S Leary, Guolian Kang, et al.
The Lancet. Oncology|April 30, 2022
Imaging response assessment for CNS germ cell tumours: consensus recommendations from the European Society for Paediatric Oncology Brain Tumour Group and North American Children's Oncology GroupGiovanni Morana, Dennis Shaw, Shannon M MacDonald, et al.
Neuro-Oncology|November 1, 2021
EANO, SNO and Euracan consensus review on the current management and future development of intracranial germ cell tumors in adolescents and young adultsDidier Frappaz, Girish Dhall, Matthew J Murray, et al.
Biological Psychiatry|April 11, 2017
Increased Extra-axial Cerebrospinal Fluid in High-Risk Infants Who Later Develop AutismMark D Shen, Sun Hyung Kim, Robert C McKinstry, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 24, 2019
Phase II Trial of Response-Based Radiation Therapy for Patients With Localized CNS Nongerminomatous Germ Cell Tumors: A Children's Oncology Group StudyJason Fangusaro, Shengjie Wu, Shannon MacDonald, et al.
Human Molecular Genetics|February 22, 2020
Longitudinal measures of RNA expression and disease activity in FSHD muscle biopsiesChao-Jen Wong, Leo H Wang, Seth D Friedman, et al.
Scientific Reports|July 4, 2024
AI driven analysis of MRI to measure health and disease progression in FSHDLara Riem, Olivia DuCharme, Matthew Cousins, et al.
Neuro-Oncology|December 1, 2021
Phase II trial of response-based radiation therapy for patients with localized germinoma: a Children's Oncology Group studyUte Bartels, Arzu Onar-Thomas, Sunita K Patel, et al.
International Journal of Radiation Oncology, Biology, Physics|January 6, 2022
A Phase 2 Trial of Response-Based Radiation Therapy for Localized Central Nervous System Germ Cell Tumors: Patterns of Failure and Radiation Dosimetry for Nongerminomatous Germ Cell TumorsErin S Murphy, Girish Dhall, Jason Fangusaro, et al.
Human Molecular Genetics|October 13, 2018
MRI-informed muscle biopsies correlate MRI with pathology and DUX4 target gene expression in FSHDLeo H Wang, Seth D Friedman, Dennis Shaw, et al.
Neuro-Oncology|June 9, 2025
Phase 3 randomized trial of high-dose methotrexate for young children with high-risk embryonal brain tumors: A report from the Children's Oncology GroupClaire Mazewski, Sarah E S Leary, Guolian Kang, et al.
The Lancet. Oncology|April 30, 2022
Imaging response assessment for CNS germ cell tumours: consensus recommendations from the European Society for Paediatric Oncology Brain Tumour Group and North American Children's Oncology GroupGiovanni Morana, Dennis Shaw, Shannon M MacDonald, et al.
Neuro-Oncology|November 1, 2021
EANO, SNO and Euracan consensus review on the current management and future development of intracranial germ cell tumors in adolescents and young adultsDidier Frappaz, Girish Dhall, Matthew J Murray, et al.
Biological Psychiatry|April 11, 2017
Increased Extra-axial Cerebrospinal Fluid in High-Risk Infants Who Later Develop AutismMark D Shen, Sun Hyung Kim, Robert C McKinstry, et al.
Pageof 3